Manama, Bahrain has stopped importing all drugs produced by the Gulf Pharmaceutical Industries (Julphar).
The National Health Regulatory Authority (NHRA) has directed government departments and the main supplier of Julphar drugs to enforce the ban.
In a statement issued today, the regulatory authority said that the ban does not apply to Julphar drugs which are currently available in the market in Bahrain.
The Saudi Food and Drug Authority (SFDA) has already temporarily suspended imports of a number of drugs produced by the Gulf Pharmaceutical Industries (Julphar), over remarks related to the principles of pharmaceutical manufacturing (GMP).
The Julphar drugs which are banned by the Saudi Food and Drug Authority (SFDA) are neither imported nor available in any private or Government-run pharmacies, said NHRA statement.
The supplier, as well as relevant public and private authorities were notified not to import Julphar drugs until the Saudi Food and Drug Authority (SFDA) lifts the ban.
Source: Bahrain News Agency